日本调查:接种首剂阿斯利康疫苗 66%出现倦怠感




日本调查:接种首剂阿斯利康疫苗 66%出现倦怠感

10/03/2021

新华社引述日本广播协会电视台报道,研究小组对今年8月以来在日本八所医疗机构接种第一剂阿斯利康疫苗的179人展开调查。(路透社)

(早报讯)日本卫生、劳动与福利部研究小组日前公布的调查结果显示,在首次接种英国阿斯利康冠病疫苗的每三人当中,大约有两人会出现倦怠感。这是日本政府首次公布有关阿斯利康疫苗不良反应的调查结果。

新华社引述日本广播协会电视台(NHK)报道,研究小组对今年8月以来在日本八所医疗机构接种第一剂阿斯利康疫苗的179人展开调查。

结果显示,大约66%的人出现倦怠感;51%的人出现头痛症状;47%的人则发烧,体温达37.5摄氏度以上。越年轻,越容易出现上述不良反应,且多见于接种后的第二天和第三天。



研究小组负责人、顺天堂大学医学系客座教授伊澄信表示,其他冠病疫苗在第二剂接种后更易出现症状,而调查数据显示,阿斯利康疫苗在第一剂接种后更易出现不良反应。

据NHK报道,截至当地时间星期六(10月2日)傍晚6时30分(新加坡时间晚上7时30分),日本新增1246起冠病确诊病例,累计确诊病例达170万3880起;新增死亡病例则有32起,累计1万7719起死例。

Source



2 out of 3 feel fatigue after 1st AstraZeneca jab

10/03/2021

Japanese researchers have found that two out of three people experienced fatigue after their first shot of the AstraZeneca coronavirus vaccine.

A research team of the health ministry analyzed the symptoms of 179 people who received their first dose at eight medical institutions across the country since August.

Sixty-six percent felt fatigue, 51 percent had headaches, and 47 percent developed a fever of 37.5 degrees Celsius or higher.

The symptoms mostly occurred one or two days after the shot and were more common among young people.



This is the first time the government has released its survey on side effects of the AstraZeneca vaccine.

Professor Ito Suminobu at the medical school of Juntendo University heads the research team.

Ito says data from clinical trials showed that recipients of the AstraZeneca vaccine more likely experienced side effects after their first jab, while recipients of other vaccines developed symptoms more often after the second dose.

The professor says his team will continue to study side effects.



The health ministry says 28,997 people in Japan had received the AstraZeneca vaccine as of September 12, and no deaths had been reported.

One-thousand 190 people had been confirmed dead after receiving either the Pfizer-BioNTech or Moderna vaccines.

The ministry says the figure per million people was 17.2 for the Pfizer-BioNTech vaccine and 2.4 for the Moderna vaccine.

Officials say no causal link to the inoculation was established in any of those cases.

Source